AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Depreciation & Amortization - Total (2022 - 2026)

Updated

AbCellera Biologics' Depreciation & Amortization - Total was $6.1 million in Q2 2026, up 32.6% from $4.6 million a year earlier and up 3.1% from the prior quarter.

Analysis

AbCellera Biologics (ABCL) Depreciation & Amortization - Total (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, AbCellera Biologics' Depreciation & Amortization - Total was $21.46 million through Jun 30, 2026, up 43.9% year-over-year; for FY2025, it was $18.44 million, up 47.1% from FY2024.

  • Depreciation & Amortization - Total shows a four-year compound annual growth rate of 43.1% (FY2021 to FY2025).
  • In earlier years, Depreciation & Amortization - Total was $12.54 million in FY2024 (-2.1%), $12.8 million in FY2023 (+42.2%), $9 million in FY2022 (+104.4%) and $4.4 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization - Total in data going back to Q1 2022.
  • Compared with a year earlier, Depreciation & Amortization - Total has increased for six straight quarters, with growth averaging 34.3% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization - Total over five years was Q4 2025 (growth of 144.7%); the worst was Q4 2024 (a decline of 46.2%).
  • Per Business Quant data, ABCL's Depreciation & Amortization - Total in the three quarters before Q2 2026 was $5.92 million (Q1 2026), $5.14 million (Q4 2025) and $4.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 AbCellera Biologics 3.89 Bn 3.89 Bn - 6.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.10 Mn
Mar 31, 2026 5.92 Mn
Dec 31, 2025 5.14 Mn
Sep 30, 2025 4.30 Mn
Jun 30, 2025 4.60 Mn
Mar 31, 2025 4.41 Mn
Dec 31, 2024 2.10 Mn
Sep 30, 2024 3.80 Mn
Jun 30, 2024 3.40 Mn
Mar 31, 2024 3.20 Mn
Dec 31, 2023 3.90 Mn
Sep 30, 2023 3.10 Mn
Jun 30, 2023 3.00 Mn
Mar 31, 2023 2.90 Mn
Dec 31, 2022 2.79 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.30 Mn
Mar 31, 2022 1.40 Mn
API Access

AbCellera Biologics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=ABCL&period=max&api_key=YOUR_API_KEY